Coronary Syndrome
📧 Sign up to get email alerts when something new happens for Coronary Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2019-08-16Clinical Trial Update: Comparison of High-dose Rosuvastatin Versus Low-dose Rosuvastatin Plus Ezetimibe on Carotid Plaque Inflammation in Patients With Acute Coronary Syndrome [Phase 4]
Phase 4 trial evaluating high-dose rosuvastatin versus low-dose rosuvastatin plus ezetimibe on carotid plaque inflammation in acute coronary…
-
CLINICAL_TRIALS trial_result · 2019-08-14Clinical Trial Update: EVOlocumab for Early Reduction of LDL-cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS) [Phase 3]
Phase 3 clinical trial update for EVOlocumab in acute coronary syndrome assessing early reduction of LDL-cholesterol levels.
-
FDA approval · 2019-08-07FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (Dr.Reddy's Laboratories Inc)
The FDA approved a supplemental application for clopidogrel bisulfate from Dr. Reddy's Laboratories Inc, indicating a supplemental approval …
-
CLINICAL_TRIALS trial_result · 2019-08-07Clinical Trial Update: Bioresorbable Polymer-Coated EES in Patients at High Bleeding Risk Undergoing PCI Followed by 1-Month DAPT [Phase 4]
Phase 4 trial update evaluating a bioresorbable polymer-coated everolimus-eluting stent in high bleeding risk patients undergoing PCI with 1…
-
CLINICAL_TRIALS trial_result · 2019-08-06Clinical Trial Update: Bivalirudin in Elderly Patients Undergoing Elective Percutaneous Coronary Intervention. [Phase 4]
Phase 4 clinical trial evaluating bivalirudin in elderly patients undergoing elective percutaneous coronary intervention; current status unk…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-08-02FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved Dr. Reddy's Laboratories' supplemental application for clopidogrel bisulfate, approving changes to the product's labeling.
-
FDA approval · 2019-08-02FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for clopidogrel bisulfate by Sun Pharmaceutical Industries, Inc. The approval covers the generic…
-
CLINICAL_TRIALS trial_result · 2019-08-01Clinical Trial Update: Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions [NA]
A completed clinical trial evaluating the safety and effectiveness of the Orsiro sirolimus-eluting coronary stent system in subjects with co…
-
FDA approval · 2019-07-25FDA Approved: BIVALIRUDIN — Original Application (MAIA Pharmaceuticals, Inc.)
The FDA approved bivalirudin under an original application from MAIA Pharmaceuticals, labeling it as an anticoagulant for use during certain…
-
CLINICAL_TRIALS trial_result · 2019-07-17Clinical Trial Update: DUAL Antithrombotic Therapy in Patients With AF and ACS [Phase 4]
Clinical trial update on dual antithrombotic therapy in patients with atrial fibrillation and acute coronary syndromes (Phase 4).
-
CLINICAL_TRIALS trial_result · 2019-07-15Clinical Trial Update: Plaque Regression and Progenitor Cell Mobilization With Intensive Lipid Elimination Regimen (PREMIER), Phase I [Phase 3]
Phase 3 trial update on intensive lipid elimination regimen for acute coronary syndrome, reporting plaque regression and progenitor cell mob…
-
CLINICAL_TRIALS research · 2019-07-15Clinical Trial Update: Is Efficacy of PLAtelet Aggregation Inhibition by Ticagrelor Mediated P2Y12 Blockade Dependent Upon Endogenous Endothelial Nitric OXide? [Phase 4]
Phase 4 trial update evaluating whether ticagrelor’s platelet inhibition efficacy is mediated by endogenous endothelial nitric oxide in acut…
-
CLINICAL_TRIALS trial_result · 2019-07-11Clinical Trial Update: Evaluating Increasing Physical Activity After Acute Coronary Syndrome [NA]
A completed clinical trial evaluated increasing physical activity after acute coronary syndrome; results were posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-07-10Clinical Trial Update: Plaque Regression and Progenitor Cell Mobilization With Intensive Lipid Elimination Regimen (PREMIER), Phase II [Phase 3]
Phase 3/Phase II trial investigating plaque regression and progenitor cell mobilization with an intensive lipid elimination regimen in acute…
-
CLINICAL_TRIALS trial_result · 2019-06-20Clinical Trial Update: Metformin Continuation Versus Interruption Following Coronary Angiography: a Pilot Randomized Controlled Trial [Phase 4]
A Phase 4 randomized trial compares continuing versus interrupting metformin after coronary angiography in patients with acute coronary synd…
-
CLINICAL_TRIALS trial_result · 2019-06-17Clinical Trial Update: Statins Evaluation in Coronary Procedures and Revascularization Trial [Phase 4]
Phase 4 clinical trial evaluating statins in coronary procedures for acute coronary syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2019-05-23Clinical Trial Update: Evaluation of Varenicline (Champix) in Smoking Cessation for Patients Post-Acute Coronary Syndrome (EVITA) Trial [Phase 3]
Phase 3 clinical trial assessing varenicline for smoking cessation after acute coronary syndrome completed with results posted.
-
FDA approval · 2019-05-16FDA Approved: AGGRASTAT — Supplemental Application (Medicure International Inc)
The FDA approved a supplemental application for AGGRASTAT (tirofiban) submitted by Medicure International Inc.
-
EMA withdrawal · 2019-05-07EMA Application withdrawn: Canakinumab Novartis (Canakinumab) — Novartis Europharm Limited
The EMA has withdrawn the application for canakinumab by Novartis Europharm Limited for indications in acute coronary syndrome, myocardial i…
-
CLINICAL_TRIALS trial_result · 2019-04-25Clinical Trial Update: Comparison of Ticagrelor vs. Prasugrel on Inflammation, Arterial Stiffness, Endothelial Function, and Circulating Endothelial Progenitor Cells in Diabetic Patients With Non-ST Elevation Acute Coronary Syndrome (NSTE-ACS) Requiring Coronary Stenting [Phase 4]
Phase 4 trial comparing ticagrelor and prasugrel on inflammation, arterial stiffness, endothelial function, and circulating endothelial prog…
-
CLINICAL_TRIALS trial_result · 2019-04-12Clinical Trial Update: The Effect on EPCs by Statin Loading in "All Comers" With an ACS [Phase 4]
Phase 4 trial update evaluating the effect of statin loading on endothelial progenitor cells (EPCs) in patients with acute coronary syndrome…
-
FDA approval · 2019-04-03FDA Approved: CLOPIDOGREL — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for clopidogrel bisulfate from Aurobindo Pharma Limited, confirming regulatory approval for this gen…
-
CLINICAL_TRIALS trial_result · 2019-03-29Clinical Trial Update: Impact of Ticagrelor on the Endothelial Healing Following Drug-eluting Stent Implantation in the Patients With Acute Coronary Syndrome [Phase 4]
A Phase 4 clinical trial assessing the effect of ticagrelor on endothelial healing after drug-eluting stent implantation in patients with ac…
-
FDA approval · 2019-03-28FDA Approved: EFFIENT — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for EFFIENT (prasugrel hydrochloride) from Cosette Pharmaceuticals, Inc., indicating updates to the …
-
CLINICAL_TRIALS trial_result · 2019-03-20Clinical Trial Update: Ticagrelor Monotherapy Compared to Aspirin Monotherapy in Patients With History of ACS [Phase 4]
Phase 4 trial comparing ticagrelor monotherapy to aspirin monotherapy in patients with a history of acute coronary syndrome has completed re…